QUOTE AND NEWS
FiercePharma  May 26  Comment 
Upcoming Novo, Sanofi combo meds eye $6B-plus market, but launches could be slow tracystaton Thu, 05/26/2016 - 11:27
newratings.com  May 26  Comment 
PARIS (dpa-AFX) - A phase II trial of investigational antibiotic Solithromycin in Japanese patients with community acquired bacterial pneumonia or CABP in short, conducted by Cempra Inc.'s (CEMP) partner Toyama Chemical has successfully met...
newratings.com  May 26  Comment 
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) recommended the approval of the New Drug Application or NDA for the...
FierceBiotech  May 25  Comment 
FDA panel backs 2nd diabetes combo, endorses Sanofi’s iGlarLixi john_carroll Wed, 05/25/2016 - 16:41
New York Times  May 25  Comment 
The French drug maker said it was seeking the consent of the American company’s shareholders to replace directors with a slate of its own candidates.
Clusterstock  May 25  Comment 
By Matthias Blamont and Noëlle Mennella PARIS (Reuters) - Sanofi will step up its push into China, its second biggest market after the United States, in the next five years as part of a wider expansion into emerging countries, where it sees a...
FiercePharma  May 23  Comment 
Sanofi shakes up management as top diabetes exec departs tracystaton Mon, 05/23/2016 - 10:48
FierceBiotech  May 23  Comment 
FDA frets over the safety of Sanofi’s diabetes combo john_carroll Mon, 05/23/2016 - 09:28




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki